福建省制药企业的发展现状及对策探讨

发布时间：2017-12-28 17:14

本文关键词：福建省制药企业的发展现状及对策探讨　出处：《中国药房》2016年28期 　论文类型：期刊论文

【摘要】：目的:为福建省制药企业的进一步发展提供参考。方法:结合福州、厦门、漳州、泉州、南平等地区制药企业的调研资料,概括福建省制药企业的整体发展情况和了解制约其发展的主要因素,并提出促进其进一步发展的措施。结果与结论:福建省制药企业的整体发展情况不容乐观,主要体现在医药政策落实不到位、企业配套服务设施不完善、人才引进机制不健全、地产药品销售因集中招标采购政策受到影响等方面;同时,企业规模偏小和利润偏低、自主研发资金投入较少、药学专业人员偏少、企业的营销能力偏弱,阻碍了其进一步发展。建议进一步强化主管机构职能,优化投资环境,完善配套服务体系和人才引进与培养机制,优选创新模式等,以促进制药企业的进一步发展。
[Abstract]:Objective: to provide reference for the further development of pharmaceutical enterprises in Fujian province. Methods: combined with the research data of pharmaceutical enterprises in Fuzhou, Xiamen, Zhangzhou, Quanzhou and Nanping, the overall development of Fujian pharmaceutical enterprises and the main factors restricting their development were summarized, and measures for further development were put forward. Results and conclusion: the overall development of pharmaceutical enterprises in Fujian is not optimistic, mainly reflected in the policy implementation is not in place, the pharmaceutical enterprises supporting service facilities are not perfect, the talent introduction mechanism is not perfect, the real estate sales for drug centralized bidding and purchasing policies affected; at the same time, small scale and low profits, independent research and development funds less, the pharmacy staff is less, the enterprise marketing ability is weak, hindering its further development. It is suggested that we should further strengthen the functions of the competent authorities, optimize the investment environment, improve the supporting service system and talent introduction and training mechanism, and optimize the innovation mode, so as to promote the further development of pharmaceutical enterprises.
【作者单位】：福建生物工程职业技术学院;
【基金】：福建省科技厅软科学项目(No.2014R0033) 福建省医药产业中试与检测技术公共服务平台资助项目(No.2014Y2008)
【分类号】：F426.72
【正文快照】： 由工业和信息化部提供的数据显示,我国的医药工业增加值增速2011年达17.5%,2012年为14.5%,2013年为12.7%,2014年为12.5%;其中2014年的增加值高于整体工业增加值4.2个百分点,在各个工业大类中位居前列[1]。根据2013年全国31个省、自治区、直辖市(不包括香港、澳门和台湾地区)的

【相似文献】